# Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)

> **NCT00686621** · — · APPROVED_FOR_MARKETING · sponsor: **Merck Sharp & Dohme LLC**

## Conditions studied

- Mycoses

## Interventions

- **DRUG:** Posaconazole

## Key facts

- **NCT ID:** NCT00686621
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** APPROVED_FOR_MARKETING
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2018-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686621, "Single Patient Treatment of Posaconazole in Invasive Fungal Infections (Study P05113)". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00686621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*